Follow
Barnaby Young
Barnaby Young
National Centre for Infectious Diseases
Verified email at ncid.sg
Title
Cited by
Cited by
Year
Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore
BE Young, SWX Ong, S Kalimuddin, JG Low, SY Tan, J Loh, OT Ng, ...
Jama 323 (15), 1488-1494, 2020
22572020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...
Science 370 (6515), eabd4585, 2020
16492020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
14352020
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
11632021
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
CW Tan, WN Chia, X Qin, P Liu, MIC Chen, C Tiu, Z Hu, VCW Chen, ...
Nature biotechnology 38 (9), 1073-1078, 2020
7912020
Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients
PY Chia, KK Coleman, YK Tan, SWX Ong, M Gum, SK Lau, XF Lim, ...
Nature communications 11 (1), 1-7, 2020
728*2020
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
R Pung, CJ Chiew, BE Young, S Chin, MIC Chen, HE Clapham, AR Cook, ...
The Lancet 395 (10229), 1039-1046, 2020
6662020
Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients
IYJ Seah, DE Anderson, AEZ Kang, L Wang, P Rao, BE Young, DC Lye, ...
Ophthalmology 127 (7), 977-979, 2020
4592020
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
Jama 320 (10), 984-994, 2018
4552018
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
BE Young, SW Fong, YH Chan, TM Mak, LW Ang, DE Anderson, CYP Lee, ...
The lancet 396 (10251), 603-611, 2020
3602020
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
AT Tan, M Linster, CW Tan, N Le Bert, WN Chia, K Kunasegaran, ...
Cell reports 34 (6), 108728, 2021
3442021
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
CM Poh, G Carissimo, B Wang, SN Amrun, CYP Lee, RSL Chee, ...
Nature communications 11 (1), 1-7, 2020
328*2020
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
PY Chia, SWX Ong, CJ Chiew, LW Ang, JM Chavatte, TM Mak, L Cui, ...
Clinical microbiology and infection 28 (4), 612. e1-612. e7, 2022
2582022
Risk factors for severe disease and efficacy of treatment in patients infected with COVID-19: a systematic review, meta-analysis, and meta-regression analysis
JJY Zhang, KS Lee, LW Ang, YS Leo, BE Young
Clinical Infectious Diseases 71 (16), 2199-2206, 2020
2572020
Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B. 1.1. 7 (Alpha), B. 1.315 (Beta), and B. 1.617. 2 (Delta)
SWX Ong, CJ Chiew, LW Ang, TM Mak, L Cui, MPHS Toh, YD Lim, ...
2512021
Discovery and genomic characterization of a 382-nucleotide deletion in ORF7b and ORF8 during the early evolution of SARS-CoV-2
YCF Su, DE Anderson, BE Young, M Linster, F Zhu, J Jayakumar, ...
MBio 11 (4), e01610-20, 2020
238*2020
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
WN Chia, F Zhu, SWX Ong, BE Young, SW Fong, N Le Bert, CW Tan, ...
The Lancet Microbe 2 (6), e240-e249, 2021
2362021
A neutralizing monoclonal antibody for hospitalized patients with Covid-19
ACTIV-3/TICO LY-CoV555 Study Group
New England Journal of Medicine 384 (10), 905-914, 2021
2362021
Epidemiological and clinical predictors of COVID-19
Y Sun, V Koh, K Marimuthu, OT Ng, B Young, S Vasoo, M Chan, VJM Lee, ...
Clinical Infectious Diseases 71 (15), 786-792, 2020
2252020
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
1782021
The system can't perform the operation now. Try again later.
Articles 1–20